Comparison of Speech Therapy and Audioprosthetic Care in Older Adults With First-time Hearing Aids

GCS Ramsay Santé pour l'Enseignement et la Recherche

Overview

The purpose of the study is to evaluate the score of the Evaluation of the Impact of Deafness in Adults(ERSA)/150 questionnaire obtained at 3 months compared to the inclusion score.

This is a pilot, prospective, interventional, comparative, randomized, longitudinal, open, multicenter study comparing synchronous and delayed hearing aid and speech therapy. Patients will be randomly divided by drawing lots into 2 groups. Both groups will benefit from a hearing aid prescription and speech therapy for a series of 24 sessions at the rate of 1 per week, for an approximate duration of 6 months. Group A will benefit from speech therapy and synchronous equipment, and group B will begin speech therapy after 3 months after the installation of the equipment. Regarding the equipment, it will not be the same for all patients. Indeed, it is the one that will best suit the patient who will be chosen. The same will apply to the settings, in accordance with the usual support.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Conditions

Hearing Loss

Interventions

Hearing aidDEVICE

Fitting a hearing aid

Speech therapy sessionOTHER

As speech therapy is part of standard care, the objective of the study will be to compare the impact of synchronous or delayed audioprosthetic and speech therapy care on the impact of deafness in elderly patients.

Eligibility

Sex: ALLMin age: 65 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient, male or female, aged 65 to 80; * First equipment; * Average hearing loss between 40 and 70 db; * Speech comprehension greater than 50%; * Absence of acoustic recruitment phenomenon; * Symmetrical bilateral deafness (inter aural difference \<20dB); * Affiliated patient or beneficiary of a social security scheme; * Patient speaking and understanding French, able to complete questionnaires and scales; * Patient having been informed and having signed an informed consent to participate in the study. Exclusion Criteria: * Patient with a psychiatric pathology; * Patient with neurological disorders; * Patient taking psychotropic drugs; * Patient participating in another clinical study; * Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision; * Patient hospitalized without consent.

Outcomes

Primary Outcomes

Assessment of the Impact of Deafness in Adults

Score of the questionnaire "Assessment of the Impact of Deafness in Adults" obtained at 3 months compared to the inclusion score. The ERSA (Evaluation of the Repercussions of Deafness in Adults) assesses four areas: quality of life, personal life, social life and professional life. It is rated out of 200 or out of 150 in the absence of professional life. The higher the ERSA score, the better the patient's quality of life.

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.